Protein Sciences (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Protein Sciences" in English language version.

refsWebsite

Global rank English rank

1^st place

447^th place

338^th place

low place

2^nd place

4^th place

5,973^rd place

3,693^rd place

low place

6,532^nd place

79^th place

65^th place

7^th place

doi.org

Treanor, John J.; Schiff, Gilbert M.; Hayden, Frederick G.; Brady, Rebecca C.; Hay, C. Mhorag; Meyer, Anthony L.; Holden-Wiltse, Jeanne; Liang, Hua; Gilbert, Adam; Cox, Manon (April 11, 2007). "Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza VaccineA Randomized Controlled Trial". JAMA. 297 (14): 1577–1582. doi:10.1001/jama.297.14.1577. PMID 17426277.

"The NIH Biomedical Research Response to Influenza". Archived from the original on November 4, 2016. Retrieved October 3, 2023.

Treanor, John J.; Schiff, Gilbert M.; Hayden, Frederick G.; Brady, Rebecca C.; Hay, C. Mhorag; Meyer, Anthony L.; Holden-Wiltse, Jeanne; Liang, Hua; Gilbert, Adam; Cox, Manon (April 11, 2007). "Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza VaccineA Randomized Controlled Trial". JAMA. 297 (14): 1577–1582. doi:10.1001/jama.297.14.1577. PMID 17426277.

Andrew Pollack, "Rapidly Produced Flu Vaccine Wins F.D.A. Approval" Archived 2017-04-26 at the Wayback Machine, The New York Times, January 16, 2013

"Sanofi to acquire Protein Sciences". sanofi.com. Archived from the original on 15 July 2017. Retrieved 27 November 2017.

"Sanofi to acquire Protein Sciences". sanofi.com. Archived from the original on 15 July 2017. Retrieved 27 November 2017.
"The NIH Biomedical Research Response to Influenza". Archived from the original on November 4, 2016. Retrieved October 3, 2023.
"NBC Connecticut: Swine Flu Vaccine Could Be Ready in 6 Weeks". Archived from the original on 2009-04-29. Retrieved 2009-05-02.
"FDA Panel to Consider New Flu Vaccine Technology". Wall Street Journal. November 13, 2009. Archived from the original on 2017-11-07. Retrieved 2009-11-20. Protein Sciences Corp. a private firm based in Meriden, Conn., is seeking Food and Drug Administration approval for its FluBlok seasonal influenza vaccine, although the same technology can be used to make an H1N1 vaccine to protect against the swine flu. The vaccine will be reviewed by outside medical experts who serve on the agency's vaccine advisory panel.
"Flublok, (Influenza Vaccine, Recombinant Hemagglutinin), Briefing Document, FDA Vaccines and Related Biological Products Advisory Committee Meeting, November 19, 2009" (PDF). Food and Drug Administration. Archived from the original (PDF) on May 14, 2017. Retrieved October 3, 2023.
Andrew Pollack, "Rapidly Produced Flu Vaccine Wins F.D.A. Approval" Archived 2017-04-26 at the Wayback Machine, The New York Times, January 16, 2013
"FDA press release". Food and Drug Administration. Archived from the original on May 18, 2013. Retrieved October 3, 2023.

"FDA Panel to Consider New Flu Vaccine Technology". Wall Street Journal. November 13, 2009. Archived from the original on 2017-11-07. Retrieved 2009-11-20. Protein Sciences Corp. a private firm based in Meriden, Conn., is seeking Food and Drug Administration approval for its FluBlok seasonal influenza vaccine, although the same technology can be used to make an H1N1 vaccine to protect against the swine flu. The vaccine will be reviewed by outside medical experts who serve on the agency's vaccine advisory panel.